Ionis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…

Biotechnology
US, Carlsbad [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of IONS's Analysis
CIK: 874015 CUSIP: 462222100 ISIN: US4622221004 LEI: - UEI: -
Secondary Listings
IONS has no secondary listings inside our databases.